Regional

North Central Oregon EMS Agencies

Name: North Central Oregon EMS Agencies EMS protocol doses
Creator: ProtoQuiz
License: https://protoquiz.com/census/data-license/

May be outdated121 dose entries34 drugs1 documentOReffective 2019-12-09100% machine-parsed of 121

The current listed document is more than 24 months old and may be outdated.

Drugs and doses34

A–C Albuterol, Amiodarone, Amyl Nitrite, Aspirin, Atropine, Calcium Gluconate, Captopril7

Albuterol

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	1 unit	NEB	not captured	standing	page 30 · source
Asthma / bronchospasm	adult	1 unit	NEB	not captured	standing	pages 75, 76 · source
Asthma / bronchospasm	adult	1 unit	NEB	not captured	standing	pages 75, 76 · source
Asthma / bronchospasm	peds	1 unit	NEB	not captured	standing	pages 75, 76 · source
Asthma / bronchospasm	peds	1 unit	NEB	not captured	standing	pages 75, 76 · source
COPD	adult	1 unit	NEB	not captured	standing	pages 75, 76 · source
COPD	peds	1 unit	NEB	not captured	standing	pages 75, 76 · source
Crush injury	adult	1 unit	NEB	not captured	standing	pages 90, 94 · source
Hyperkalemia	adult	1 unit	NEB	not captured	standing	pages 17, 90 · source

Amiodarone

Indication	Population	Dose	Route	Repeat	Standing	Source
Wide-complex tachycardia	adult	150 mg	IV/IO	not captured	standing	pages 16, 21, 24, 26 · source
Wide-complex tachycardia	peds	2.5 mg/kg	IV/IO	not captured	standing	pages 16, 21, 24, 26 · source
VF / pulseless VT	adult	300 mg	IV/IO	not captured	standing	pages 15, 20, 21 · source
VF / pulseless VT	peds	5 mg/kg	IV/IO	not captured	standing	pages 15, 20, 21 · source

Amyl Nitrite

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	0.3 mL	NEB	not captured	standing	page 71 · source

Aspirin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	324 mg	PO	not captured	standing	pages 22, 37 · source

Atropine

Indication	Population	Dose	Route	Repeat	Standing	Source
Bradycardia	adult	0.5 mg	IV	not captured	standing	pages 25, 27 · source
Bradycardia	peds	0.02 mg/kg	IV	not captured	standing	pages 25, 27 · source
Cardiac arrest	adult	2 mg	ET	not captured	standing	page 11 · source
Cardiac arrest	peds	0.04 mg/kg	ET	not captured	standing	page 11 · source
Organophosphate poisoning	adult	2 mg	IV/IO/IM	not captured	standing	page 71 · source

Calcium Gluconate

Indication	Population	Dose	Route	Repeat	Standing	Source
Hyperkalemia	adult	1 g	IV/IO	not captured	standing	page 18 · source

Captopril

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	12.5 mg	SL	not captured	standing	page 77 · source

D–F Dexamethasone, Dextrose, Diphenhydramine, Ecallantide, Epinephrine, Fentanyl, Furosemide7

Dexamethasone

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	10 mg	IV/IO/IM/PO	not captured	standing	pages 29, 76 · source
Asthma / bronchospasm	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	pages 29, 76 · source
Other	adult	10 mg	IV/IO/IM/PO	not captured	standing	pages 29, 76 · source
Other	peds	0.6 mg/kg	IV/IO/IM/PO	not captured	standing	pages 29, 76 · source

Dextrose

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	0.5 g/kg	IV/IO	not captured	standing	pages 32, 33, 44 · source
Hypoglycemia	peds	0.5 g/kg	IV/IO	not captured	standing	pages 32, 33, 44 · source

Diphenhydramine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	25 mg	IM	not captured	standing	page 68 · source
Agitation	adult	25 mg	IV/IO	not captured	standing	page 68 · source
Allergic reaction	adult	25–50 mg	IV/IO/IM	not captured	standing	page 31 · source
Allergic reaction	peds	1 mg/kg	IV/IO/IM	not captured	standing	page 31 · source

Ecallantide

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	30 mg	SQ	not captured	standing	page 54 · source

Epinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Anaphylaxis	adult	0.3–0.5 mg	IM/SQ	not captured	standing	pages 30, 31, 84 · source
Anaphylaxis	adult	0.3–0.5 mg	IV/IO	not captured	standing	pages 31, 84 · source
Anaphylaxis	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 31, 84 · source
Anaphylaxis	peds	0.2 mg	IM/SQ	not captured	standing	pages 30, 31, 84 · source
Asthma / bronchospasm	adult	0.1–0.25 mg	IV/IO	not captured	standing	page 76 · source
Asthma / bronchospasm	adult	0.1–0.5 mg	IM/SQ	not captured	standing	page 76 · source
Asthma / bronchospasm	peds	0.01 mg/kg	IV/IO	not captured	standing	page 76 · source
Cardiac arrest	adult	1 mg	IV/IO	not captured	standing	pages 15, 17, 20, 21 · source
Cardiac arrest	adult	2 mg	ET	not captured	standing	page 11 · source
Cardiac arrest	peds	0.01 mg/kg	IV/IO	not captured	standing	pages 15, 17, 20, 21 · source
Stridor	adult	3 mg	NEB	not captured	standing	page 76 · source
Stridor	peds	3 mL	NEB	not captured	standing	page 76 · source

Fentanyl

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	25–50 mcg	IV/IO	not captured	standing	page 38 · source
Burns	adult	25 mcg	IV/IO/IM	not captured	standing	pages 35, 36 · source
Burns	peds	1–2 mcg/kg	IV/IO/IM	not captured	standing	pages 35, 36 · source
Mild to moderate pain	adult	25–50 mcg	IV/IO/IM/IN	not captured	standing	pages 66, 91 · source
Mild to moderate pain	peds	1 mcg/kg	IV/IO/IM/IN	not captured	standing	pages 66, 91 · source

Furosemide

Indication	Population	Dose	Route	Repeat	Standing	Source
CHF / pulmonary edema	adult	20–40 mg	IV/IO	not captured	standing	page 77 · source
Crush injury	adult	40 mg	IV	not captured	standing	pages 90, 95 · source

G–L Glucagon, Haloperidol, Hydroxycobalamin, Ipratropium, Ketamine, Lidocaine, Lorazepam7

Glucagon

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	1 mg	IM/SQ	not captured	standing	pages 32, 33, 44 · source
Hypoglycemia	peds	0.1 mg/kg	IM/SQ	not captured	standing	pages 32, 33, 44 · source

Haloperidol

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2–5 mg	IV/IO	not captured	standing	pages 68, 69 · source
Agitation	adult	5–10 mg	IV/IO/IM	not captured	standing	page 69 · source
Agitation	adult	5 mg	IM	not captured	standing	page 68 · source
Nausea / vomiting	adult	1.25 mg	IV/IM	not captured	standing	page 57 · source

Hydroxycobalamin

Indication	Population	Dose	Route	Repeat	Standing	Source
Cyanide poisoning	adult	5 g	IV/IO	not captured	standing	page 71 · source
Cyanide poisoning	peds	70 mg/kg	IV/IO	not captured	standing	page 71 · source

Ipratropium

Indication	Population	Dose	Route	Repeat	Standing	Source
Allergic reaction	adult	1 unit	NEB	not captured	standing	page 30 · source
Allergic reaction	peds	1 unit	NEB	not captured	standing	page 30 · source
Asthma / bronchospasm	adult	1 unit	NEB	not captured	standing	pages 75, 76 · source
Asthma / bronchospasm	adult	1 unit	NEB	not captured	standing	pages 75, 76 · source
Asthma / bronchospasm	peds	1 unit	NEB	not captured	standing	pages 75, 76 · source
Asthma / bronchospasm	peds	1 unit	NEB	not captured	standing	pages 75, 76 · source
COPD	adult	1 unit	NEB	not captured	standing	pages 75, 76 · source
COPD	peds	1 unit	NEB	not captured	standing	pages 75, 76 · source

Ketamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	5 mg/kg	IM	not captured	standing	page 68 · source
Mild to moderate pain	adult	25 mg	IV/IO	not captured	standing	page 66 · source
Mild to moderate pain	adult	50 mg	IM	not captured	standing	page 66 · source
Mild to moderate pain	peds	0.3 mg/kg	IV/IO	not captured	standing	page 66 · source

Lidocaine

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	3 mg/kg	ET	not captured	standing	page 11 · source
Cardiac arrest	peds	3 mg/kg	ET	not captured	standing	page 11 · source
Wide-complex tachycardia	adult	1.5 mg/kg	IV/IO	not captured	standing	pages 21, 24, 26 · source
Wide-complex tachycardia	peds	1.5 mg/kg	IV/IO	not captured	standing	pages 21, 24, 26 · source
VF / pulseless VT	adult	1–1.5 mg/kg	IV/IO	not captured	standing	pages 15, 16, 20, 21 · source
VF / pulseless VT	peds	1 mg/kg	IV/IO	not captured	standing	pages 15, 16, 20, 21 · source

Lorazepam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	0.5–2 mg	IV/IO/IM	not captured	standing	pages 68, 69 · source
Procedural sedation	adult	0.5–2 mg	IV/IO/IM	not captured	standing	page 23 · source
Seizure	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 79, 80 · source

M–O Magnesium Sulfate, Midazolam, Morphine, Naloxone, Nitroglycerin, Norepinephrine, Olanzapine, Ondansetron, Oxymetazoline9

Magnesium Sulfate

Indication	Population	Dose	Route	Repeat	Standing	Source
Asthma / bronchospasm	adult	2 g	IV/IO	not captured	standing	page 76 · source
Asthma / bronchospasm	peds	25–50 mg/kg	IV/IO	not captured	standing	page 76 · source
Eclampsia / pre-eclampsia	adult	2–4 g	IV/IO	not captured	standing	page 65 · source
VF / pulseless VT	adult	2 g	IV/IO	not captured	standing	pages 16, 20, 21, 24, 26 · source
VF / pulseless VT	peds	25 mg/kg	IV/IO	not captured	standing	pages 16, 20, 21, 24, 26 · source

Midazolam

Indication	Population	Dose	Route	Repeat	Standing	Source
Agitation	adult	2–10 mg	IV/IO/IM/IN	not captured	standing	pages 68, 69 · source
Procedural sedation	adult	2–5 mg	IV/IM	not captured	standing	pages 23, 24, 26 · source
Procedural sedation	adult	2.5 mg	IV/IO/IM	not captured	standing	pages 25, 27 · source
Procedural sedation	peds	0.1 mg/kg	IV/IO/IM	not captured	standing	pages 25, 27 · source
Procedural sedation	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 23, 24, 26 · source
Seizure	adult	2–5 mg	IV/IO/IM/IN	not captured	standing	pages 79, 80 · source

Morphine

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	1–2 mg	IV/IO	not captured	standing	page 38 · source
Burns	adult	2–5 mg	IV/IO/IM	not captured	standing	page 35 · source

Naloxone

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	adult	4 mg	ET	not captured	standing	page 11 · source
Cardiac arrest	peds	0.1 mg/kg	ET	not captured	standing	page 11 · source
Respiratory distress	adult	0.4–2 mg	IV/IO/IM/IN	not captured	standing	pages 21, 32, 33, 71, 79 · source
Respiratory distress	peds	0.1 mg/kg	IV/IO/IM/IN	not captured	standing	pages 21, 32, 33, 71, 79 · source

Nitroglycerin

Indication	Population	Dose	Route	Repeat	Standing	Source
ACS / chest pain	adult	0.4 mg	SL	not captured	standing	pages 37, 38 · source
CHF / pulmonary edema	adult	0.4 mg	SL	not captured	standing	page 77 · source
Other	adult	0.4 mg	SL	not captured	standing	page 55 · source

Norepinephrine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypotension / shock	adult	4–12 mcg	IV/IO	not captured	standing	pages 84, 85 · source
Hypotension / shock	adult	4 mcg	IV/IO	not captured	standing	page 14 · source
Other	peds	0.1–0.15 mcg/kg	IV/IO	not captured	standing	page 21 · source
Sepsis	adult	4–12 mcg	IV/IO	not captured	standing	pages 81, 85 · source

Olanzapine

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	10 mg	PO	not captured	standing	page 69 · source

Ondansetron

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	4 mg	IV/IM	not captured	standing	pages 57, 58 · source
Nausea / vomiting	adult	4 mg	PO	not captured	standing	pages 57, 58 · source
Nausea / vomiting	peds	0.1 mg/kg	IV/IM	not captured	standing	pages 57, 58 · source
Nausea / vomiting	peds	2 mg	PO	not captured	standing	pages 57, 58 · source

Oxymetazoline

Indication	Population	Dose	Route	Repeat	Standing	Source
Other	adult	2 spray	IN	not captured	standing	page 49 · source

P–R Pralidoxime, Promethazine2

Pralidoxime

Indication	Population	Dose	Route	Repeat	Standing	Source
Nerve agent exposure	adult	600 mg	IM	not captured	standing	page 71 · source

Promethazine

Indication	Population	Dose	Route	Repeat	Standing	Source
Nausea / vomiting	adult	12.5–25 mg	IV	not captured	standing	page 57 · source

S–Z Sodium Bicarbonate, Thiamine2

Sodium Bicarbonate

Indication	Population	Dose	Route	Repeat	Standing	Source
Cardiac arrest	peds	1 mEq/kg	IV/IO	not captured	standing	pages 18, 20, 21 · source
Hyperkalemia	peds	1 mEq/kg	IV/IO	not captured	standing	pages 18, 20, 21, 71 · source
Other	adult	1 mEq/kg	IV/IO	not captured	standing	pages 16, 21, 71 · source
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 16, 21, 71 · source
Other	peds	1 mEq/kg	IV/IO	not captured	standing	pages 18, 21 · source

Thiamine

Indication	Population	Dose	Route	Repeat	Standing	Source
Hypoglycemia	adult	100 mg	IV/IM	not captured	standing	page 44 · source
Other	adult	100 mg	IV/IM	not captured	standing	pages 33, 42 · source
Seizure	adult	100 mg	IV/IM	not captured	standing	page 79 · source

Cite this

North Central Oregon EMS Agencies, United States EMS Protocol Census. 121 dose entries, effective 2019-12-09.

https://protoquiz.com/census/agencies/north-central-oregon-ems-agencies/

Outdated or wrong? Fix or remove it All Oregon agencies Methodology Data license Study these protocols in the app

The census is free and not for sale. Only public agencies are named.